Last Update 27 Apr 26

CHAMBLFERT: Steady Earnings Assumptions And Upcoming Results Meeting Will Support Upside

Analysts have kept their fair value estimate for Chambal Fertilisers and Chemicals steady at ₹559.50 per share, citing unchanged assumptions around revenue growth, profit margins and future P/E, even though discount rate inputs have been marginally refreshed.

Analyst Commentary

Bullish Takeaways

Bullish analysts view the unchanged fair value estimate of ₹559.50 per share as consistent with their thesis that Chambal Fertilisers and Chemicals has a reasonably clear earnings profile under the current set of revenue and margin assumptions.
The willingness to refresh discount rate inputs while keeping core drivers steady is seen as a sign that the valuation work is being regularly updated, rather than relying on outdated macro or rate assumptions.
Supporters of the stock highlight that a stable P/E assumption signals confidence in the company’s ability to sustain its current earnings power, instead of relying on a higher multiple to justify the fair value.
Some bullish commentators point out that steady assumptions can help investors frame expectations more clearly, since shifts in share price can be compared directly against a consistent valuation anchor.

Bearish Takeaways

Bearish analysts argue that keeping revenue and margin assumptions unchanged, even as discount rate inputs move, may not fully capture potential business risks or execution challenges that could affect cash flows.
There is concern that relying on a stable future P/E could underplay scenarios where market sentiment toward fertiliser names compresses valuations, which would put pressure on the fair value.
Some cautious views suggest that modest tweaks to discount rates, while maintaining the same earnings profile, might give a sense of precision that does not fully reflect uncertainty around input costs or regulatory changes.
Critics also note that a static fair value can sometimes lag behind shifts in investor preference across sectors. This could influence how quickly the market re-rates Chambal Fertilisers and Chemicals over time.

What's in the News

A board meeting is scheduled for February 10, 2026 to consider and approve the standalone unaudited financial results for the quarter and nine months ended December 31, 2025 (Key Developments).
The same board meeting will also review and approve the consolidated unaudited financial results for the quarter and nine months ended December 31, 2025, with group-level performance in focus for investors who track the wider business (Key Developments).

Valuation Changes

Fair Value: The fair value estimate remains unchanged at ₹559.50 per share, with no adjustment to the core valuation output.
Discount Rate: The discount rate has risen slightly from 12.89% to 12.92%, reflecting a marginal update to the rate input.
Revenue Growth: The revenue growth assumption is effectively steady at about 5.04%, with only a minor numerical refinement in the model.
Net Profit Margin: The net profit margin input remains around 8.02%, with no meaningful shift in the underlying profitability assumption.
Future P/E: The future P/E multiple has been nudged up slightly from 16.93x to 16.94x, indicating only a very small adjustment to the valuation multiple used.

9 views

Key Takeaways

Diversification into new agri-input segments and digital initiatives is strengthening Chambal's growth resilience and market positioning.
Supportive government policies and capital-efficient strategies enhance margin stability and long-term earnings potential.
Heavy dependence on urea, aging infrastructure, volatile input costs, and slow diversification pose significant risks to future profitability and revenue stability.

Catalysts

About Chambal Fertilisers and Chemicals

Produces and sells fertilizers primarily in India.What are the underlying business or industry changes driving this perspective?

Chambal is rapidly diversifying its revenue streams beyond urea by aggressively expanding businesses in crop protection chemicals, specialty nutrients, biologicals, and seeds-segments that saw 32%+ YoY growth and frequent new launches, which positions the company to benefit from India's long-term transition to more nutrient-efficient, sustainable agriculture and increases resilience in topline and net margins.
The company is leveraging its strong rural distribution network, digital platforms (Uttam Farmer Connect, WhatsApp chatbot), and farmer outreach programs to scale new product adoption, supporting both near-term and long-term revenue growth as agriculture input demand rises with population and food needs.
Government policies are creating a stable and supportive environment for fertiliser demand and urea profitability by continuing subsidy payments, introducing measures to protect against raw material price shocks, and maintaining price controls over core products (urea, DAP, TSP), boosting volume stability and underpinning EBITDA/margin stability.
Chambal's capital allocation focus-evidenced by a strong net cash position (₹1,600 crores), investment in energy efficiency, pipeline of operational cost reduction projects, and soon-to-commence Technical Ammonium Nitrate (TAN) plant-signals improving margin profiles and potential for future earnings growth as cost efficiencies materialize and new value-added products ramp up.
Long-term industry and macro trends-such as India's structurally rising agricultural input demand, chronic under-capacity in domestic urea, expectations of healthy demand-supply dynamics in TAN (mining/coal expansion), and market consolidation-position Chambal to capture greater market share and drive sustained growth in revenue and earnings.

Chambal Fertilisers and Chemicals Earnings and Revenue Growth

Chambal Fertilisers and Chemicals Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Chambal Fertilisers and Chemicals's revenue will grow by 5.0% annually over the next 3 years.
Analysts assume that profit margins will shrink from 9.4% today to 8.0% in 3 years time.
Analysts expect earnings to reach ₹19.0 billion (and earnings per share of ₹47.43) by about April 2029, down from ₹19.1 billion today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting ₹22.4 billion in earnings, and the most bearish expecting ₹16.4 billion.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 16.9x on those 2029 earnings, up from 9.3x today. This future PE is lower than the current PE for the IN Chemicals industry at 22.2x.
Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
To value all of this in today's terms, we will use a discount rate of 12.92%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Chambal Fertilisers' heavy reliance on urea for the bulk of its revenue (with frequent discussion of government-regulated pricing, ever-tightening energy norms, and its vulnerability to changes after the 8-year Gadepan-III policy expires) means that any future government policy shift (such as tighter subsidy regimes, transition to nutrient-based subsidies, or reduced subsidy payouts) could result in significant revenue volatility and compressed net margins.
The company's core manufacturing plants are aging, with recurring mentions of unscheduled breakdowns (e.g., Gadepan-II downtime leading to lost volumes) and required efficiency upgrades; this increases the risk of rising maintenance costs, unplanned shutdowns, large capex outlays, and ultimately, operational inefficiencies that can erode overall profitability.
Sustained high or volatile natural gas prices (a key input for urea production, with the company indicating input price pass-through only in certain regulated environments) can erode sector margins, especially as the government tightens energy consumption norms; this could negatively impact both EBITDA and net profit.
The secular trend towards sustainable, environmentally friendly, and organic farming practices-as evidenced by increasing investment in biologicals, specialty nutrients, and partnerships for R&D-may gradually compress the long-term demand for legacy synthetic fertilizer products, threatening future revenue growth in Chambal's core business.
Delays in diversification beyond core fertilizers-crop protection, seeds, and complex fertilizer expansion plans remain small in contribution or "work in progress" with no assurance on market penetration or alliances; this exposes Chambal to medium-term concentration risk and dependency on traditional, regulated fertilizer earnings, which may hamper future revenue and earnings stability.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of ₹559.5 for Chambal Fertilisers and Chemicals based on their expectations of its future earnings growth, profit margins and other risk factors.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be ₹237.1 billion, earnings will come to ₹19.0 billion, and it would be trading on a PE ratio of 16.9x, assuming you use a discount rate of 12.9%.
Given the current share price of ₹445.95, the analyst price target of ₹559.5 is 20.3% higher. Despite analysts expecting the underlying business to decline, they seem to believe it's more valuable than what the market thinks.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Chambal Fertilisers and Chemicals?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Agricultural Diversification Will Boost Prospects But Risk Regulatory Shifts